As some firms want to make and sell drugs similar to biological medicines made by the likes of Amgen and Genentech, a measure aims to regulate their use.
SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs.
via L.A. Times - Health http://feeds.latimes.com/~r/latimes/features/health/~3/2vVZl9tZNAM/la-fi-0513-capitol-business-beat-20130513,0,6254628.story
SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs.
via L.A. Times - Health http://feeds.latimes.com/~r/latimes/features/health/~3/2vVZl9tZNAM/la-fi-0513-capitol-business-beat-20130513,0,6254628.story
No comments:
Post a Comment